These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18828648)

  • 1. Tight blood glucose control.
    Bloomgarden ZT
    Geriatrics; 2008 Oct; 63(10):3; author reply 3. PubMed ID: 18828648
    [No Abstract]   [Full Text] [Related]  

  • 2. Tight blood glucose control.
    Frank SJ
    Geriatrics; 2008 Oct; 63(10):3; author reply 3. PubMed ID: 18828649
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.
    Wareham NJ; Pfister R
    Nat Rev Cardiol; 2010 Jul; 7(7):367-8. PubMed ID: 20577298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [European guidelines on diabetes, pre-diabetes and cardiovascular diseases: what's new?].
    Urbinati S; Bordoni B
    G Ital Cardiol (Rome); 2014 Jun; 15(6):345-9. PubMed ID: 25072419
    [No Abstract]   [Full Text] [Related]  

  • 5. Individualizing glycemic targets in type 2 diabetes mellitus.
    Aron D; Conlin PR; Hobbs C; Vigersky RA; Pogach L
    Ann Intern Med; 2011 Sep; 155(5):340-1. PubMed ID: 21893635
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes Management Update: Individualizing Treatment.
    Reid T
    J Fam Pract; 2019 Oct; 68(8):S13-S19. PubMed ID: 31697797
    [No Abstract]   [Full Text] [Related]  

  • 7. Four decades of uncertainty: landmark trials in glycaemic control and cardiovascular outcome in type 2 diabetes.
    Matthews DR; Tsapas A
    Diab Vasc Dis Res; 2008 Sep; 5(3):216-8. PubMed ID: 18777497
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intensive glucose control in type 2 diabetes is beneficial].
    Nilsson PM; Attvall S
    Lakartidningen; 2009 Sep 2-8; 106(36):2198. PubMed ID: 19817174
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypoglycemia and cardiovascular risk].
    Avogaro A
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):4S-12S. PubMed ID: 25623545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of diabetes mellitus: implications of the use of oral agents.
    Rao SV; Bethel MA; Feinglos MN
    Am Heart J; 1999 Nov; 138(5 Pt 1):S334-7. PubMed ID: 10539794
    [No Abstract]   [Full Text] [Related]  

  • 11. New insights into the older hypoglycemic agents in type 2 diabetes therapy.
    Cao M; Bloomgarden Z
    J Diabetes; 2020 Nov; 12(11):844-847. PubMed ID: 32767624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comment from the diabetology viewpoint].
    Stahl M
    Praxis (Bern 1994); 2008 Aug; 97(17):943-4. PubMed ID: 18777777
    [No Abstract]   [Full Text] [Related]  

  • 13. [Questions for practicing internists].
    Zinnenlauf S
    Praxis (Bern 1994); 2008 Aug; 97(17):945-6. PubMed ID: 18777778
    [No Abstract]   [Full Text] [Related]  

  • 14. Daily glycaemic variability: benefits of optimal control.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():1-2. PubMed ID: 24034512
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing postprandial glucose levels in patients with diabetes.
    Tenzer-Iglesias P; Brunton S
    J Fam Pract; 2008 Jan; 57(1 Suppl Managing):S17-24. PubMed ID: 18662529
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glycemic control and cardiovascular benefit: what do we know today?].
    Egidi G; Popert U
    Dtsch Med Wochenschr; 2011 May; 136(19):1027; author reply 1027-8. PubMed ID: 21544796
    [No Abstract]   [Full Text] [Related]  

  • 17. Case study 1: exploring the pharmacologic agents for treatment of type 2 diabetes.
    Martin CL
    Diabetes Educ; 2007; 33 Suppl 1():6S-13S. PubMed ID: 17272803
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetes. Paradoxical effects of tightly controlled blood sugar.
    Taubes G
    Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
    [No Abstract]   [Full Text] [Related]  

  • 19. Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.
    Mannucci E; Monami M; Ceriello A; Rotella CM
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):375-377. PubMed ID: 28242233
    [No Abstract]   [Full Text] [Related]  

  • 20. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.